Standard-Essential Patents and FRAND Licensing for Technology Companies

What makes a patent standard-essential?

Technical standards allow products and systems made by different companies to interoperate. Wireless communications, video compression, connectivity, automotive systems and many other technology markets rely on standards. A patent becomes commercially important in this context when implementing a mandatory part of a standard necessarily practices one or more patent claims.

That does not mean every patent declared to an SDO is necessarily valid, infringed or essential. Declarations can be broader than the set of patents ultimately proven essential. For a transaction, licensing negotiation or dispute, the useful diligence question is claim-specific: which claim limitation maps to which mandatory portion of the standard, and can a compliant implementation avoid that claim?

FRAND is a licensing commitment, not a predetermined royalty number

Standards-developing organizations commonly seek assurances that technologies selected for a standard will be available for licensing on reasonable and non-discriminatory, or fair, reasonable and non-discriminatory, terms. The precise language differs among organizations. The 2022 joint DOJ, USPTO and NIST withdrawal notice expressly observed that specific FRAND commitments are contractual obligations that vary by SDO.

A technology company should therefore avoid beginning the analysis with a generic percentage. First identify the operative commitment. Then determine the portfolio and products within scope, whether the relevant patents are essential, and what evidence supports the proposed economic terms. Comparable agreements may be probative, but they are not mechanically interchangeable. Differences in portfolio size, geographic coverage, standard generation, licensed products, cross-licenses, settlement context, timing and bargaining position can materially affect comparability.

Non-discrimination also requires context. It does not necessarily mean that every licensee receives identical headline terms. The relevant inquiry can include whether similarly situated licensees are treated consistently after accounting for legitimate differences in scope, value, risk and transaction structure.

How to evaluate a FRAND licensing offer

A disciplined review should separate legal scope from economic terms. The first stage tests whether the offer covers rights and products that require a license. The second stage evaluates the methodology used to derive the proposed royalty and whether the supporting evidence is sufficiently transparent to permit a reasoned response.

The objective is not merely to label an offer “FRAND” or “not FRAND.” The stronger record explains which assumptions are accepted, which are disputed, what information is missing, and what alternative terms are supported by the available technical and economic evidence.

FRAND terms in technology transactions and M&A

SEP exposure can affect acquisitions, financing, product launches, vendor arrangements and technology licenses. Buyers should identify whether the target owns declared SEPs, implements standards that may require third-party licenses, participates in SDOs, or has entered portfolio licenses that contain change-of-control, assignment or affiliate provisions.

For sellers, diligence should distinguish revenue-generating licensing rights from contingent assertions. For buyers, historical non-assertion, cross-license and covenant arrangements may matter as much as headline royalty obligations. A transaction model should also identify standards implemented by products that are expected to remain in market after closing.

SEP diligence belongs alongside software-license, open-source, patent, data and cybersecurity diligence. The goal is to connect a technical standards dependency to concrete transaction consequences such as valuation, closing conditions, representations, indemnities, integration planning or future licensing budget.

Questions for SEP holders

An SEP holder should be prepared to explain why the asserted rights are essential, which products and territories are covered, how the proposed rate was derived and how comparable agreements were selected. If a portfolio offer uses representative patents, the methodology for choosing those patents should be documented.

Licensors should also verify the continuing status of patents and declarations. Expired or lapsed rights, family members with materially different claim scope, and patents tied to obsolete standard releases can distort a portfolio presentation if they are not separated from the live licensing set.

Where non-discrimination is relevant, a record of comparable licensee treatment can be important. Confidentiality obligations may limit disclosure of individual agreements, but the underlying analysis should still identify what makes proposed comparators similar or different.

Primary U.S. policy and agency sources

SEP and FRAND disputes are highly fact specific. SDO rules, patent rights, contract law, remedies and competition analysis can differ across jurisdictions and over time. Current sources and governing agreements should be checked for each matter.